Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9348 USD | +0.52% | +8.70% | -15.78% |
Mar. 15 | Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.78% | 50.49M | |
+9.37% | 221B | |
+7.59% | 184B | |
+18.60% | 142B | |
+18.48% | 101B | |
+8.10% | 68.07B | |
+25.79% | 57.27B | |
-2.49% | 47.42B | |
+5.47% | 43.19B | |
+15.02% | 28.84B |
- Stock
- Equities
- Stock Cytosorbents Corporation - Nasdaq
- News Cytosorbents Corporation
- Cytosorbents' : CytoSorb Blood Purification Technology Gets Nod from South Korean Regulator